As a rapid-acting insulin, Merilog helps to lower mealtime blood sugar spikes to ... The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three biosimilar insulin ...
(RTTNews) - The U.S. Food and Drug Administration announced that Sanofi-Aventis ... to lower mealtime blood sugar spikes to improve control of blood sugar in people with diabetes.
Digital health company Health2Sync will work with Sanofi on digitising its range ... patients that is designed to help them improve blood glucose control by encouraging adherence – for example ...
and Indigo Diabetes. TB received honoraria for participating on the speaker’s bureaux of Eli Lilly, Novo Nordisk, Medtronic, Abbott, Sanofi, Dexcom, Aventis, Astra Zeneca, and Roche. TB’s ...
It helps lower mealtime blood sugar spikes ... is expected to enhance patient access to safe and effective diabetes treatments. The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA ...
Approximately 8.4 million rely on insulin therapy to effectively manage their blood glucose levels ... Approval of Merilog has been granted to Sanofi-Aventis U.S. LLC, adding to the growing ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control in adults and pediatric patients with diabetes mellitus. The regulatory ...
Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback